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Currently, one in three American adults suffer from high blood pressure, a condition 
known as hypertension, yet only half have their condition under control (CDC, 2016). 
Methods of continuous blood pressure measurement have been examined by the team 
over the past few years. Using five hemodynamic interventions to fluctuate blood 
pressure, blood pressure data was gathered from 35 healthy adult participants. This 
data was useful in measuring pulse transit time and determining optimal locations for 
biosensor placement. Participants were also surveyed to collect public opinion on 
potential health monitoring devices for future development. Furthermore, the 
potential of using mobile device applications was examined as an alternative method 
of retrieving signals and calculating blood pressure. The results from this project 
indicate that for a mobile device application, the best signals to use for estimating 
  
blood pressure are PPG maximum to ECG R-wave, having an average correlation of -
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Chapter 1: Introduction 
Due to the current rise in blood pressure (BP) related diagnoses, medical 
practitioners are searching for a more effective method of monitoring vital patient 
information (Marshall, 2004). Currently, one in three American adults suffer from high 
blood pressure (HBP), a condition known as hypertension (Center for Disease Control 
and Prevention [CDC], 2016). Astoundingly, only about half of the people who suffer 
from hypertension have their condition under control (CDC, 2016). Today, the 
predominant method of monitoring BP is achieved through visiting a doctor, which 
lacks the efficiency and convenience that could exist if there was a way for patients to 
continuously monitor their own BP. High blood pressure was a contributing cause of 
death for upwards of 400,000 Americans in 2014 (CDC, 2016). With proper preventive 
care, many of these deaths could have been avoided. Due to these alarming trends, 
frequent BP monitoring is necessary. 
There are numerous logistical drawbacks to the current methods of obtaining 
BP measurements due to inconvenience, inconsistency, and inaccuracy. The time and 
money involved with periodically visiting a doctor is the root of America’s problem 
with hypertension, contributing to overall patient noncompliance and thus trivializing 
the importance of consistent BP measurements. Even for those able to regularly visit 
healthcare facilities, an annual BP measurement from a doctor is simply insufficient, 
because BP is a constantly changing measurement that fluctuates according to the 
current condition of the body. For instance, excitement and exercise can create short-





(National Heart, Lung, and Blood Institute [NHLBI], 2015). Even the stress associated 
with seeing a doctor, medical trainee, or other healthcare professional has been shown 
to cause a sudden spike in blood pressure during readings, a phenomenon known as 
white coat hypertension (Handler, 2009; Matthys et al., 2004; NHLBI, 2015). 
Therefore, to precisely gauge an accurate and aggregate BP measurement, it must be 
measured constantly, underscoring the need to develop a method of continuous BP 
monitoring to promote preventive care within at-risk populations. Moreover, improper 
techniques of taking blood pressure, such as miscuffing, may lead to incorrect readings 
(NHLBI, 2015). Overestimating or underestimating blood pressure by 5 to 10 mm Hg 
can subsequently lead to incorrect diagnoses (Handler, 2009). One proposed alternative 
is to allow patients to take more frequent measurements from the comfort of their home 
(Marshall, 2004) which would increase practicality and decrease costs. Alternative 
methods of blood pressure estimation are warranted.  
Chapter 2: Literature Review 
2.1: Background 
Blood pressure is the force of blood pushing against arterial walls as it is 
pumped from the heart (NHLBI, 2015). There are two different types of pressure 
measurements that are jointly quantified to come up with a BP measurement. Systolic 
pressure (SBP) measures the pressure inside the arteries as the heart pumps blood, 
while diastolic pressure (DBP) conversely measures the pressure of the arteries when 
the heart is resting between beats (CDC, 2014). A normal, healthy BP for adults is 
conventionally defined as having an SP below 120 millimeters of Mercury (mmHg) 





SBP in the numerator and DP in the denominator of a fraction, as 120/80 mmHg 
(NHLBI, 2015). Fluctuations in BP are extremely common, and are often noticed when 
active, excited, or nervous, or between periods of sleep and consciousness (NHLBI, 
2015). The most accurate measurement of resting BP would be taken during rest 
periods between activities that could contribute to these fluctuations. 
 
Figure 1. A typical PPG waveform depicting the difference in systolic and diastolic 
peak. 
 
When the heart beats, blood is pumped into vessels that travel throughout the 
body (World Health Organization [WHO], 2013). Hypertension causes a greater force 
to be pushed against these vessels. In terms of systolic and diastolic blood pressure, 
hypertension is a common disease that occurs when blood flows through the arteries at 
a higher than normal pressure, resulting in blood pressure readings higher than the 





has to pump. Prehypertension, in which blood pressure numbers are slightly higher than 
normal—a warning sign of hypertension—ranges from SP readings from 120-139 or 
DP readings from 80-89 (NHLBI, 2015). Having either a systolic or diastolic pressure 
greater than these benchmarks, meaning greater than 140/90 mmHg, is categorized as 
hypertension.  
Although anyone can develop high blood pressure (HBP), there are several 
factors that can increase the risk of developing this condition, such as age, weight, 
lifestyle habits, sex, race/ethnicity, family medical history, or pregnancy. Blood 
pressure often increases with age, as nearly two-thirds of Americans over the age of 60 
have been diagnosed with hypertension (American Heart Association [AHA], 2016). 
As an individual ages, a layer of protein in the blood vessels that enhances flexibility, 
known as elastin, degenerates. Naturally, this causes the vessels to thicken and become 
stiff, resulting in higher systolic BP (NHLBI, 2015).  Similarly, the risk for high blood 
pressure is much higher in individuals who are overweight and have poor diets, 
exercise, or lifestyle habits (AHA, 2016). This includes being physically inactive and 
consuming an excessive amount of sodium or alcohol (NHLBI, 2015).  
In terms of sex, men under the age of 55 generally have a greater risk for 
developing cardiovascular diseases when compared to women. After this age, higher 
blood pressure is often found in menopausal women (Reckelhoff, 2001). Studies have 
confirmed this finding by identifying a higher prevalence of hypertension in women 
above the age of 60 years (Maranon & Reckelhoff, 2013). Regarding race/ethnicity, 
African Americans have higher average blood pressure and an earlier onset for 





Furthermore, a longitudinal study conducted over ten years found that children 
with a family history of hypertension also had higher average systolic BP when 
compared with children who did not have a family history of the disease (Munger, 
Prineas, & Gomez-Marin 1988). These patterns of persistently elevated blood pressure 
existed prior to adolescence in these children, suggesting that familial conditions may 
predict the likelihood of developing cardiovascular conditions. Interestingly, there was 
a greater correlation between a mother’s BP and her child’s when compared to the 
father’s BP and his child’s (Munger, Prineas, & Gomez-Marin 1988). Additionally, 
having a sensitivity to sodium, which increases the risk of developing high BP, may be 
a familial trait (NHLBI, 2015). These findings suggest that family history is a 
hereditary and non-modifiable risk factor associated with hypertension.  
Moreover, hypertension was found in a sample of 5-7% of pregnancies and in 
about 8% of women of reproductive age (Lindheimer, Taler, & Cunningham, 2008; 
Bateman et al., 2012). A sudden increase in BP during the third trimester of pregnancy, 
known as preeclampsia, can cause serious complications to both the fetus and mother. 
For the fetus, high BP during pregnancy can decrease blood flow to the placenta, which 
leads to less oxygen, fewer nutrients, and lower birth weight. In some cases, it may 
result in preterm delivery to prevent lethal complications (Lindheimer, Taler, & 
Cunningham, 2008; NHLBI, 2015). For the mother, high BP may damage internal 
organs, such as the kidneys, or increase the likelihood of developing cardiovascular 
disease in the future (Mayo Clinic, 2018).  
Many of the symptoms of hypertension, if not diagnosed or treated in due time, 





to as “the silent killer”, because symptoms usually do not appear until the body has 
already been damaged from chronic HBP (AHA, 2016; WHO, 2013).  
The most common and severe complications caused by chronic HBP include 
the increased risk of aneurysms and strokes, as well as kidney, heart, eye, and arterial 
damage (AHA, 2016). The arteries are the most adversely damaged from HBP, as the 
force exerted by blood onto the arteries causes microscopic tears in arterial walls that 
can lead to further damage (AHA, 2016). Damaged arteries accumulate cholesterol, fat, 
and plaque buildup, which increase the risk of peripheral or coronary artery disease. 
These life-threatening illnesses occur from the accumulation and hardening of plaque 
within the vessels, which clog and narrow the arteries. 
Similarly, abnormal balloon-like bulges, called aneurysms, may also develop 
in the walls of the arteries as a result of blood pressure that is too forceful for arterial 
walls to withhold, further exacerbating arterial damage (AHA, 2016). Aneurysms grow 
for years before causing any noticeable symptoms, until they rupture, dissect, or grow 
large enough to block blood flow in the vessels. This blockage can cause strokes when 
the flow of oxygen-rich blood to the brain is restricted (AHA, 2016). A comparable 
situation arises when the heart is not receiving the oxygen-rich blood that it relies on, 
which can lead to a heart attack (NHLBI, 2015). In these circumstances, hypertension 
has the potential to cause severe physiological damage to the body through heart 







2.2: Existing Technology 
With an increase in health monitoring concerns, more and more people in the 
developed world are turning to devices that can effectively record physical activity and 
pertinent vital signs (Haghi, Thurow & Stoll, 2017). Since the mid-20th century, with 
the advent of the wearable pedometer (Haghi, Thurow & Stoll, 2017), it is clear that 
there is a growing desire for patients to monitor their own health, as it can assist their 
doctors in better serving them and allow for timely control over lifestyle changes when 
necessary. However, in order to achieve these goals, such devices must be improved to 
have the ability to measure one of the most widely monitored vital signs, blood 
pressure, in an accurate manner. 
Improper techniques regarding blood pressure measurements can lead to severe 
and sometimes fatal consequences. Underestimating or overestimating true blood 
pressure measurements by just 5 mmHg would misdiagnose over 20 million Americans 
with prehypertension, or cause 30 million Americans to possibly receive erroneous 
treatment (Handler, 2009). The consequence underdiagnosing, which is largely 
attributed to inappropriate measuring techniques, has the capability of increasing the 
amount of strokes and myocardial infarctions by approximately 25% (Handler, 2009). 
On the other hand, overdiagnosing could increase medical costs or the potential for 
adverse drug effects. Therefore, it is imperative that the advantages and limitations of 
these devices are assessed in an objective manner to ensure that appropriate treatment 
is administered to patients with concerning blood pressure levels. 
Existing methods of obtaining BP, such as catheterization, auscultation, and 





measurements instantly by placing a gauge in direct contact with blood flow 
(Mukkamala et al., 2015). Although this method provides an instant and accurate 
reading, it is an invasive procedure that is simply not feasible for daily use.  Perhaps 
the most commonly recognized clinical method of obtaining BP involves the process 
of auscultation. Using this method, systolic and diastolic BP are measured through an 
inflatable cuff. A medical professional then uses a stethoscope to find Korotkoff 
sounds,  which are audible changes in the flow of blood, during cuff deflation. Systolic 
blood pressure is estimated using the first sound and diastolic blood pressure is 
estimated using the fifth (Mukkamala et al., 2015). The major benefit to this method is 
that it is noninvasive, but the drawback is that it usually requires the assistance of a 
trained medical personnel and can be quite time consuming. Lastly, oscillometry is 
another noninvasive option of measuring BP by using oscillated amplitudes from a 
sensor placed in a cuff. Although this is a popular method of obtaining blood pressure, 
this strategy of measurement is not sensitive enough for those with stiff arteries  
The current gold standard method for measuring blood pressure is the 
sphygmomanometer (Ogedegbe & Pickering, 2010; Poon & Zhang, 2006), commonly 
known as the “blood pressure cuff” which is an auscultatory method. This method is 
ubiquitous in any healthcare facility and involves an inflatable cuff and a stethoscope 
to measure systolic and diastolic blood pressure. In order to measure these systolic and 
diastolic values, health care practitioners wrap the inflatable cuff around the brachial 
artery in the upper arm and use a stethoscope to calculate the respective values via 





used and simplest form of blood pressure monitoring, there are several limitations that 
should be considered when implementing this method.  
The biggest flaw associated with the sphygmomanometer method is that it lacks 
continuity, meaning patients are unable to continuously monitor their blood pressure at 
any given time. Instead, they must wait two minutes between measurements for the 
cuff to inflate if they need a more accurate reading, often making the process quite time 
consuming  (Gesche, Grosskurth, Kuchler, & Patzak, 2012).  This lapse in 
measurements prevents patients with short-term blood pressure fluctuations from 
precisely monitoring their health in an uninterrupted manner, thus complicating the task 
of taking blood pressure measurements.  
In addition to these limitations, there are common mistakes that can be made 
when using the sphygmomanometer that result in physiological and psychological 
spikes in blood pressure values. For example, “miscuffing” refers to an improper 
practice when health care professionals accidentally use the wrong size cuff or place 
the cuff on an incorrect area of the arm (Handler, 2009). The size of the cuff must be 
proportional to the diameter of the arm to prevent overestimating blood pressure 
(Ogedegbe & Pickering, 2010). Furthermore, proper sphygmomanometer procedures 
require the cuff to be wrapped around a bare upper arm while the forearm is positioned 
at heart level and supported on a table  (Handler, 2009). Cuffing over clothing, 
wrapping the cuff around the forearm, or using a cuff that is too small will result in 
false positives that are much higher than normal (see Table 1 for factors affecting BP 
readings). Thus, practitioners who are calculating blood pressure must be cognizant of 





Equally important to consider is the psychological stress that may arise and 
produce incorrect measurements if the patient experiences white coat hypertension. 
Copious studies have revealed that people tend to become more nervous, and thus have 
a higher record of systolic blood pressure, in the presence of a medical professional or 
medical environment (Handler, 2009; Matthys et al., 2004). Because of this, multiple 
measurements should be taken in a variety of settings over time to ensure the accuracy 
of the diagnosis. White coat hypertension further emphasizes the need for patients to 
have the freedom of monitoring their health in the comfort of their home (Marshall, 
2004; Ogedegbe & Pickering, 2010).  
 






2.2.1 Dinamap. Another technique used to measure blood pressure was the 
Dinamap (Device for Indirect non-invasive Automatic Mean Arterial Pressure). This 





oscillometric principle, which expresses pressure measurements using both the 
maximum (systolic) and minimum (diastolic) blood pressure (Flaherty, Sher, & Caro, 
2000).  In its most basic form, the Dinamap uses a cuff to place pressure onto an artery 
while the pressure of the cuff is raised in increments to points above the systolic BP 
and points below the diastolic BP (Flaherty et al., 2000).  This allows the device to 
compute a mean arterial pressure by using both the maximum and minimum blood 
pressures. Usually, the cuff begins at an inflation of 160 mmHg and then increases 
incrementally until the inflation of the cuff reaches a level 35 mmHg higher than the 
patient’s previous systolic reading (Flaherty et al., 2000). From there, the cuff deflates 
at a rate of 3-6 mmHg per second and the arterial pressures are recorded by the device 
as the cuff deflates by each increment. A pressure transducer, which is attached to the 
cuff, indicates the volume of the artery. When the artery has a larger volume, the 
pressure of the cuff will be higher (Flaherty et al., 2000).  
Although this method has been in use for a considerable amount of time, it is 
often extremely time consuming as it relies on multiple cardiac cycles in order for it to 
finally produce a reading (Hutton, Dye, & Prys-Roberts, 1984). Furthermore, the cost 
of the device makes it less than ideal for a home device, especially for patients with 
low socioeconomic backgrounds. A functional Dinamap device ranges from $500-
$2,400, excluding maintenance costs, which makes it a less accessible form of 
measuring blood pressure for some demographics (Hutton et al., 1984). 
2.2.2 Finapres. The Finapres is a device that uses the Penaz principle to 
determine blood pressure. The Penaz principle states, “a force exerted by a body can 





& Langton, 2007).” The Finapres incorporates this notion through their device by 
utilizing a small, ring-sized cuff that is wrapped around or slipped over a finger to 
record systolic and diastolic measurements (Imholz et al., 1988). The cuff itself is 
connected to a machine that interprets the waveform and displays the blood pressure 
reading. When the Finapres was first developed, readings had an average +/-7 mmHg 
error, making it a reasonable method to record blood pressure (Imholz et al, 1988).   
The company responsible for the Finapres technology has since improved upon 
their design and now offers four different devices that utilize the same method of blood 
pressure recording. Some of the models are even designed to connect with laptop 
computers to make data access and management more convenient. However, the flaws 
with this device are rather evident: it is large, cumbersome, and has several components 
that must be carried in a waistband in order to serve its desired purpose of being 
“portable.” According to Finapres, another issue with this device is its price point: at 
$40,000 per unit, it is essentially inaccessible and unnecessary for most people outside 
of the medical profession. Therefore, this device has largely been restricted to users in 
a clinical setting. This provides sufficient evidence to support the necessity of 
developing a more cost effective and truly portable method of blood pressure 
measurement that is convenient for patient use. 
2.2.3 ccNexfin. A more recent development using noninvasive technology 
continuous blood pressure measurements is the ccNexfin. This device is a blood 
pressure cuff that fits on the finger and automatically inflates and deflates in order to 
capture the blood pressure waveform in the subject’s index finger artery (Trinkmann et 





beat information on cardiac output and blood pressure (Schattenkerk, 2009). The 
Nexfin clamps the pulsating finger artery in order to apply pressure and generate a 
pressure waveform (Sipkens et al., 2011). The non-invasiveness of this latest 
development is an attractive innovation in the realm of surgical procedures, in which 
only a small percentage of patients can receive the standard, invasive intra-arterial line 
for continuous BP measurement due to the many associated complications (Sipkens et 
al., 2011). 
2.2.4 Apple Watch. A more recent breakthrough in the realm of health 
monitoring devices is Apple’s 2018 release of information on their Apple Watch 4. The 
Apple Watch, which already measures the most common health data and vital signs 
such as steps taken, distance moved, heart rate, and sleep quality will now reportedly 
have the capability to conduct electrocardiogram (ECG) testing. A traditional EKG 
requires several electrodes to give a reading of the heart’s electrical activity, but the 
Apple Watch 4 creates a more accessible method to give these readings, which can lead 
to a quicker diagnosis of conditions such as atrial fibrillation (AFib), an irregular or 
rapid heart rate that can increase the risk of a stroke, heart failure, and many other 
cardiac conditions. Conditions like AFib can be intermittent and often asymptomatic, 
but dangerous to an individual’s health, as it can double the risk of heart-related death 
if left untreated (American Heart Association [AHA] News, 2018). 
Apple is able to achieve these EKG readings by having the user place their 
finger on the screen for 30 seconds. The watch face contains electrodes, and, combined 
with the heart-rate sensor on the back of the watch, the app will determine if the heart 





within the device, and a PDF can be generated to share with healthcare professionals 
for further evaluation and/or testing. Despite creating cutting-edge technology and 
leading the field of health-monitoring smart watches, Apple still has not developed a 
device capable of continuous blood pressure measurements (AHA News, 2018). The 
company has proven, though, that health monitoring technology can be taken to the 
level of the individual, and is both possible and necessary for individuals to have 
consistent access to this information. As heart disease remains a prominent illness in 
American adults, and one of the most substantial medical issues worldwide, research 
to improve accuracies and capabilities of portable health-monitoring devices will 
continue to evolve. 
2.3 Cardiovascular Sensing 
There is a clear and present public health need for the development of a cuffless, 
non-invasive blood pressure measurement system. Existing biometric sensing 
technologies can be adapted and combined in order to help improve blood pressure 
estimation. In this section, the physical properties of acceleration, electricity, and light 
using readily available sensors will be discussed.  
2.3.1 Electrocardiogram. With each heartbeat, the heart generates electrical 
activity that can be sensed with a device known as an electrocardiogram (ECG; Ashley 
& Niebauer, 2004). The ECG uses leads which are electrical sensors placed on specific 
locations of the body. One lead is attached to the right arm and one lead is attached to 
the left arm, one lead is attached to the left leg, and one grounding lead is attached to 
the right leg. The ECG then graphs the data from these sensors on a plot, generating an 





abnormalities and pathologies. The R-peak represents the point in the ECG complex 
where the ventricles, depolarize and contract (Ashley & Niebauer, 2004). The 
ventricles are the largest chambers of the heart, creating the largest amount of 
depolarization, and thus create a sharp peak that is easy to detect using an automated 
computer analysis of the waveform. The R-peak (shown in Figure 2 below), while 
having no direct correlation to blood pressure, can be used as a reference for the 
moment when blood is being ejected from the heart and a pulse wave is generated. The 
applications of the R-peak as a proximal timing reference will be discussed later as a 
component of pulse transit time. 
 
Figure 2 The electrocardiogram interval for one heartbeat. 
 
2.3.2 Photoplethysmography. Photoplethysmography (PPG) is a simple, non-
invasive technique that is used to detect changes in blood volume in the arteries (Allen, 





shines a light-emitting diode (LED) at a typical wavelength of 640 nm (Jeong, Ko, 
Hwang, & Yoon, 2006). A photodiode, a semiconductor device that converts light into 
current, is used to sense this light (Jeong et al., 2006). The photodiode measures the 
light reflected back on the device, as the rest of the light is absorbed into the arterial 
blood, venous blood, and tissue (Elgendi, 2012). When the light is emitted onto an 
extremity, the blood vessels in the skin reflect and absorb a measurable amount of light. 
As long as the photodiode response to the light is linear, the output voltage is 
proportional to the light falling on the photodiode (Held, 2016). The amount of blood 
coursing through the arteries changes the amount of light that is reflected back. More 
blood in the arteries will allow for less light to reflect back to the photodiode, while 
less blood will allow for more light to reach the photodiode (Elgendi, 2012). The light 
that the photodiode reads changes the voltage created by the diode, with a higher 
voltage corresponding to a larger amount of light sensed by the photodiode (Jeong et 
al., 2006). By recording and calculating the difference in the amount of light absorbed 
over time, it is able to determine the changes in blood volume (Jeong et al., 2006). 
These changes in blood volume caused by the beating of the heart are often 
graphed over time in order to produce a waveform called a photoplethysmogram. 
Photoplethysmograms contain valuable information about an individual’s 
cardiovascular system, which can be used to measure blood pressure (Allen, 2007). The 
graph in Figure 3 provides a representation of the light measured by the photodiode, 
represented in volts, over time with the peaks right before the contracting of the heart 
and the troughs right after the contracting of the heart (Jeong et al., 2006). As seen in 





distance from the peak to the next trough is the diastolic time (t2) (Teng & Zhang, 2003). 
The peaks on the Figure 3 are called the systolic peaks and the smaller bump afterwards 









Figure 3. Systolic time shown as t1and diastolic time shown as t2   
(Teng & Zhang, 2003) 
 
Features found in a single PPG wave such as the systolic and diastolic time 
(Figure 3) have been shown to correlate to blood pressure with varying degrees of 
success (Kurylyak, Lamonaca, Grimaldi, 2013). In one case, PPG was shown to have 
some power in predicting BP within a relatively small group of 15 healthy subjects 





standard error of 0.02 mmHg in the diastolic pressure and 0.21 mmHg in the systolic 
pressure with standard deviations of 4.39 mmHg and 7.32 mmHg respectively (Teng 
& Zhang, 2003).  Although these results appear promising, the limited sample size 
included test subjects that were all young, healthy males meaning that many 
confounding variables did not apply. These findings may not hold true when applied to 
a different demographic, such as an older population, because of confounding factors 
such as stiffer arterial walls that tend to be present in older populations (Shaltis, 
Reisner, & Asada, 2006). Therefore, it is important to consider additional factors such 
as age, sex, and weight when determining an alternative method of BP measurement. 
One significant confounding factor is arterial stiffness, which changes with age 
and can cause the PPG wave to change shape when compared to people with more 
flexible arterial walls (Shaltis et al., 2006). This can change the shape of the PPG 
waveform by smoothing it out and making it difficult to measure features such as the 
diastolic peak of the waveform (Allen, 2007). Arterial stiffness can also change with 
ambient temperature of the measurement site, affecting the amplitude of the wave and 
obscuring the measurement (Allen, 2007).  People with heart conditions that cause 
irregular heartbeats, called arrhythmias, can change the shape of the PPG waveform 
and make it difficult to measure systolic peaks and diastolic troughs as well (Allen, 
2007). 
Furthermore, there is a significant difference in blood pressure between the 
blood flowing in the heart and the blood flowing in the finger that will also make BP 
difficult to measure using a single PPG wave. To combat this issue, one study used a 





distance from the heart to the base of the finger (Shaltis et al., 2006).  This method 
required inconvenient equipment that the average person would typically not wear, 
while disregarding the possible changes in arterial stiffness that could result from 
changes in temperature or age (Allen, 2007). Although this study found success in using 
PPG to measure blood pressure, it is important to consider the implications of other 
factors such as practicality and efficiency when developing a BP measurement device.  
A similar study by Kurylyak and colleagues (2013) was conducted using a 
single PPG signal and a neural network to determine blood pressure using the systolic 
and diastolic width of the PPG wave at various points along the PPG signal. This 
method was very effective in predicting the blood pressure from a large number of 
subjects with a mean error of 3.80+/-3.46mmHg in the systolic and 2.21+/-2.09mmHg 
in the diastolic (Kurylyak et al., 2013). These values are within the acceptable range 
denoted by the American National Standards of the Association for the Advancement 
of Medical Instrumentation of a mean absolute difference of 5 mmHg and a standard 
deviation of less than +/-8 mmHg. (Kurylyak et al., 2013). However, accessibility 
serves as the main flaw with this method since the use of a neural network requires a 
significant amount of processing, which may make it incompatible with a phone or 
other device with limited processing power. Neural networks also require significant 
amounts of training for each individual, which will require retraining as an individual 
ages because of the changes in arterial wall stiffness (Kurylyak et al., 2013). This 
highlights the need for a simpler and more convenient alternative to continuously 





Overall, these studies do not show very promising results in relying solely on a 
single PPG signal to predict BP because there lacks an appropriate theory to explain 
why a correlation may exist.  It also requires the control of confounding variables since 
the standard error in these measurements tends to be large when dealing with subjects 
with stiffer arterial walls or other confounding factors.  Since PPG is shown to measure 
heart rate very well and can be used on multiple locations on the body such as the ear, 
toe, and finger, it is probably best to use this method for precise heart rate monitoring 
alone (Allen, 2007). Thus, it may be beneficial to consider using PPG in conjunction 
with another tool of measurement to gain more accuracy in BP readings. 
2.3.3 Accelerometer (Seismocardiogram/ Ballistocardiography).   
Ballistocardiography (BCG) waveforms are measurements of the movements of the 
body directly caused by the heartbeat of a subject (Giovangrandi et al., 2014). These 
subtle movements are measured by a accelerometer that is either attached to the subject 
or placed underneath the subject. BCG waveforms can be measured by a scale that the 
subject stands on. This scale measures the body’s longitudinal motion generated by the 
ejection of the blood at each cardiac cycle (Giovangrandi et al., 2014). This waveform 
is typically less reliable to measure than other forms due to the fact that subjects can 
throw off the measurements by not remaining completely still. The movements of 
subjects shifting their balance can cause significant noise in the resulting data.  
A sample BCG wave can be seen in figure 4 below, as well as labels for each 
peak and trough of the waveform. For this study we were focusing on the IJK part of 
the wave and more specifically the I trough and the J peak. The IJK part of the wave is 





peak is the easiest part of the IJK part of the wave to detect with data containing 
significant noise, which was expected in this experiment. The I trough and J peak, while 
having no direct correlation to blood pressure, can be used as references for the moment 





Figure 4. Sample BCG waveform (Kim et al. 2016) 
 
Seismocardiogram (SCG) is the recording of the micro-scale precordial 
vibrations resulting from beating heart and blood flow into the vascular tree. These 
vibrations can be acquired by small and cost-effective accelerometers, which makes 
acquisition of SCG in wearable configuration feasible (Shafiq et al. 2016). It is 
common for the accelerometer to be placed on the chest of the subject during testing 
to more accurately measure their heart motions. The SCG waveform is typically 





shifting and/or heavy breathing of the subject. A typical SCG signal is shown in 
Figure 5. The peaks in the SCG signal correspond to opening and closing of aortic 
(AO/AC) and mitral (MO/MC) valve while the IM point occurs during the period of 
rapid change in ventricular pressure (Shafiq et al. 2016). For this study we will be 
focusing on the AO peak of the wave. The AO peak of the wave, while having no 
direct correlation to blood pressure, can be used as a reference for the moment when 
blood is being ejected from the heart as a proximal timing reference that will be 




Figure 5. Average SCG waveform (Shafiq et al. 2016) 
 
 
2.3.4 Pulse Transit Time. Pulse transit time (PTT) is the time that it takes for 
a single pulse wave to travel between two reference points down an arterial pathway 
(Smith, Argod, Pépin, & Lévy, 1999). A combination of a proximal and distal sensors 
are used to create timing references for pulse waves to calculate PTT. Once PTT is 





shown to be positively correlated with systolic blood pressure, therefore PTT would 
decrease with increasing blood pressure (Kim et al., 2015). 
PTT can be measured using several different methods, one of which entails 
measuring an individual’s pulse from one point on their body to another through the 
use of PPG sensors attached to two different locations on a person’s body (McCombie, 
Reisner, & Asada, 2006). The method of measuring PTT using two PPG sensors are 
described in this paper as “pulse-to-pulse” transit time in order to differentiate it from 
other methods of obtaining PTT. Pulse-to-pulse transit time should be gathered through 
the use of two inline PPG sensors, a known distance apart, on the same appendage 
(McCombie et al., 2006). For example, sensors can be placed along the ulnar artery at 
the wrist and the base of the pinky finger (McCombie et al., 2006). Different sensor 
locations, such as the finger and toe, can also be used (Tsai et al., 2005). Points on the 
waveforms generated by the PPG sensors are identified and the time between the two 
are recorded. For example, the onset of the pulse waveform of proximal wrist sensor is 
timed to the onset of the pulse waveform of the distal index finger PPG sensor. The 
PTT data gathered from the dual PPG sensors can be used to determine one’s blood 
pressure after a calibration is conducted (McCombie et al., 2006). 
PTT can be written as a function of a thinly walled vessel elasticity according 
to the Moens-Korteweg equation (McCombie et al., 2006). Vessel elasticity can then 
be written as a function of pressure. A combination of both provides an equation for 
the relationship between PTT and blood pressure (McCombie et al., 2006). In order to 
calibrate a device that uses dual PPG sensors for accurate blood pressure monitoring, 





blood pressure taken using a standardized and clinically used device such as a 
sphygmomanometer (McCombie et al., 2006).  Algorithms need to be written that 
consider changes in arm height as hydrostatic pressure at one’s extremities changes as 
the extremity is raised above or below the heart (Beevers, Lip, & O’Brien, 2001).  
Another technique involves an electrocardiogram (ECG; Chen, Kobayashi, 
Ichikawa, Takeuchi, & Togawa, 2000). An ECG can measure biological rhythms; 
therefore, it is capable of measuring blood pressure through PTT.  The ECG to pulse 
technique is an accurate way to track blood pressure consistently because there appears 
to be a clear linear relationship with systolic blood pressure and pulse transit time (Chen 
et al., 2000). For the most accurate reading, a previous study states that the second 
finger of the hand is the most optimal location for the distal PPG sensor (Chen et al., 
2000). An accelerometer will also be tested in our study as a proximal timing reference 
in lieu of ECG. It can be strapped to the individual’s chest or be incorporated into a 
scale that then senses the contraction of the heart during systole which references the 
point at which blood is ejected from the heart and a pulse wave is generated. 
This method of measuring blood pressure by utilizing pulse transit time is not 
perfect, since there are multiple variables that could confound the data and lead to 
inaccurate results. A root cause of this complication stems from the fact that the 
measurement is taken over two points in the body. Abnormal local changes of the 
peripheral arterial wall can create an issue with the accuracy of the measurements (Foo, 
2007). Another common factor is arterial wall stiffness, also known as arteriosclerosis, 
which is caused by the buildup of plaque on the arterial walls and can be associated 





subjects with hypertension have stiffer arterial walls and therefore are more likely to 
confound transit time related parameters (Foo, 2007).  Therefore, this method will be 
less useful for individuals who have hypertension.  
2.4 Interventions and Blood Pressure Fluctuations 
Blood pressure is highly variable and is able to react to various forms of external 
stimulation. Researchers have measured fluctuations in BP using interventions in a 
controlled lab setting that mimic natural changes in BP occurring within the body. 
When conducting interventions to measure BP, a baseline BP level is determined 
through a rest period (Martin et al., 2016). This is typically done before the start of the 
intervention and between each intervention. This rest period prevents the effects of one 
intervention from interfering with the next, which is known as carryover effects (see 
Figure 6 for common hemodynamic interventions).  
 The cold pressor test is a common procedure done to cause a rapid increase in 
the BP of the participant. It involves a procedure which requires the local extremity of 
a participant, such as an arm, to be quickly immersed into ice water (Hines & Brown, 
1936). This produces a profound thermosensory stimulus that causes a physiological 
response in the body. Studies that have repeated this procedure have also found a 
similar pattern in BP response to this stimulus, which validates the procedure’s 
consistency. A major advantage to this intervention is that it is noninvasive and 
minimally harmful to the participant. 
 Another intervention done to increase BP involves mental arithmetic (Al’Absi 
et al., 1997). Research has shown that mental arithmetic is a publicly salient task, much 





shown to increase cardiovascular activity including heart rate and systolic and diastolic 
BP (Steptoe, 2000). An intervention involving mental arithmetic requires a participant 
to complete timed mental mathematical problems in front of the researchers. Prior 
research has suggested that mental arithmetic results in substantial cardiovascular, 
endocrine, and cortisol responses in subjects and negative overall mood following the 
intervention. Psychologically, the mental arithmetic and public speaking tasks invoke 
anxiety and stress. Although public speaking tasks often produce more profound 
physiological activity (higher SBP, DBP, and heart rate), mental arithmetic is a viable 
alternative that produces similar effects to a lesser degree.  
 Furthermore, breath holding can also be used to temporarily increase the BP of 
an individual. The process of breath holding involves a vasomotor stimulus that is 
related to physiological changes. Studies using a sample of females have found that 
holding your breath increases heart rate and arterial blood pressure (Grunovas et al., 
2016). The BP returned back to normal during a five minute break. The findings from 
this study suggest the temporary nature of BP fluctuations. Similar results were found 
in men doing resistance training (Linsenbardt, Thomas, & Madsen, 1992) who 
experienced higher systolic and diastolic BP when holding their breath compared to 
other breathing exercises.  
 Finally, slow breathing has the opposite effect on blood pressure. Deep and 
slow breathing has been shown to temporarily dilate blood vessels, causing them to 
reach a relaxed state (Canadian Association of Retired Persons, 2006). A study 
comparing an intervention and control group found that using interactive music or 





2001; Elliott et al., 2007). Deep abdominal breathing is also a common practice in 
relaxation and meditation techniques that have been linked with reduced levels of BP 
(Elliott et al., 2004). Like the aforementioned interventions, slow breathing is a 
temporary and noninvasive methods of fluctuating BP.  
 Figure 6 below shows the changes in BP and HR that would be observed with 
the introduction of each intervention. The abbreviations in Figure 6 are labeled as 
follows: R1 is rest period 1, CP is cold pressor test, R2 is rest period 2, MA is mental 
arithmetic, R3 is rest period 3, SB is slow breathing, R4 is rest period 4, BH is breath 




Figure 6. Average BP and heart rate changes during human subject study. R1-5= Rest 
periods 1-5, CP= Cold pressor, MA= Mental arithmetic, SB= Slow breathing, BH= 







2.5 Research Objectives 
The primary objective of this research project was to identify signal pairs for 
measuring pulse transit time that correlate closely with blood pressure. This would 
allow researchers to identify proximal and distal sensor location pairs that could be 
used in the calculation of pulse transit time. A human subject study was designed using 
previously validated hemodynamic interventions in order to achieve this goal. The 
second objective was to examine the feasibility of using integrated sensors on a mobile 
device in the measurement of blood pressure.  
2.6: Summary 
The purpose of this project was to advance knowledge regarding the 
calculation of pulse transit time and its relation to obtaining a blood pressure 
measurement. Specifically, it was hypothesized that pulse transit time could be 
obtained using biometric sensors located in various positions of the human body. 
Furthermore, it was hypothesized that existing sensors on a mobile device could be 
used in order to obtain a blood pressure measurement. This study was important 
because many people are vulnerable to the adverse effects of elevated blood pressure, 
which leads to long term medical complications. Addressing these risks early is an 
essential component to enhancing preventative care. If blood pressure could be 
measured conveniently at a low cost, more individuals could become aware of 
potentially lethal cardiovascular conditions. The findings from this study could 
inform the development of future interventions to reduce the adverse effects of 
hypertension. Moreover, these results could offer alternate methods of investigating 





Chapter 3: Methodology 
3.1 Human Subject Study  
In order to test the accuracy of various sensor placements against the Nexfin, 
the human subject subteam decided to obtain blood pressure measurements from a 
group of participants. Once approval was received from the Institutional Review Board, 
participants who met the inclusion criteria were recruited via word of mouth to 
participate in the study. Team members recruited students from the University of 
Maryland, College Park. Participants between the ages of 18-70 who were not pregnant 
and had no previous history of cardiovascular concerns were encouraged to participate 
in the study. On oral overview of the study was provided prior to the beginning of the 
study. They had to sign papers including a consent form and a form acknowledging 
understanding of these aforementioned criteria. They were informed that they could 
withdraw from the study if they experienced discomfort at any time.  
For the study, participants completed a one-hour long series of interventions to 
fluctuate and measure BP. A ten question survey was briefly administered to 
participants at the conclusion of their participation to obtain their feedback on the 
process and opinions on the sensors. Survey data was collected from 28 participants. 
Some participants chose not to complete the survey. As compensation, participants 
received $20 in cash for the hour long study and survey. Participants then signed a form 
acknowledging the receipt of this payment. Participation was voluntary and subjects 
had the opportunity to conclude the study earlier or take breaks as needed. Sensitive 





the participants. All other personally identifying information were removed from 
analysis. Data were collected during the fall of 2017 and spring of 2018. 
3.1.1 Participants. The participants in this study were 35 University of 
Maryland, College Park students aged 18 to 23. All participants were above the age of 
18, had no prior history of cardiovascular conditions, and were not pregnant. During 
analysis, data from 15 participants were not viable and subsequently excluded due to 
errors in data collection or due to logistical difficulties in the analysis. One of the 15 
participants was unable to complete the interventions and withdrew from the study. 
Thus, the final sample for analysis included data collected from 20 participants. 
 Participants varied in terms of academic major, race/ethnicity, exercise routine, 
and demographic background. In total, participants ranged in age from 18-23 years, 
with a mean age of 20. Regarding sex, 14 participants (40%) identified as female, 20 
identified as male (57.14%), and one was not reported (2.86%). The weight of the 
participants ranged from 107 lbs to 205 lbs with the average weight being 154.54 lbs 
(see Table 2 for demographics). Height ranged from 157.5 cm to 193 cm with the 
average being 173.56 cm. In terms of race/ethnicity, participants were predominantly 
White/Caucasian (62.86%) followed by Asian (20.0%), Black/African American 










Table 2. Participant Demographics 
 
Demographic Variable (n=35)   
Male 20 participants (60%) 
Female 14 participants (40%) 
Average Weight 154.54 lbs 
Weight Range 107-200 lbs 
Average Height 173.56 cm 
Height Range 157.5-193 cm 
Average Age 20 years 
Age Range 18-22 years 
Average Body Mass Index (BMI) 22.59 
BMI Range 17.6-28.1 
White/Caucasian 22 participants (62.86%) 
Asian 7 participants (20.0%) 
Black/African American 5 participants (14.29%) 
Hispanic/Latino 2 participants (5.71%) 
 
3.1.2 Instrumentation. Subject information including age, height, weight, and 
sex was entered into the Nexfin machine. A BioPac MP150 machine was also used to 
collect data using the BioPac AcqKnowledge Software. Subjects stood on a 
predesigned BCG scale (Martin et al., 2016) that resembled a traditional bathroom 





sensor signals were recorded on this software. Signals from the ECG, BCG (scale), 
BCG (accelerometer), and BP from the Nexfin were all collected and recorded in the 
AcqKnowledge software (see Figure 7 for an illustration /of the signal recordings). 
Prior to the initiation of the interventions, lab team members examined the waveforms 
to ensure R-waves were identifiable in the ECG signals, I, J, and K waves were 
identifiable in the BCG signal, and systolic and diastolic peaks were identifiable in the 
Nexfin signal. 
 On the right side of the participant’s body, one electrode was placed on their 
upper chest (see Figure 8 for a diagram of sensor placement). A Nexfin was placed on 
their wrist and middle finger. Various sized finger cuffs (extra small, small, medium, 
large) were used to ensure participant comfort and detection of signals. The cuff was 
wrapped around the middle phalanx of the right hand middle finger.  An accelerometer 
was placed on their upper arm. The left side of the body had two more electrodes, one 
placed on the upper chest and another placed near the waistline. All three electrode 
leads were attached to the ECG input of the BioNomadix Transmitter. This transmitter 










Figure 7.  Photo and diagram depicting location of sensor placements 
 






3.1.3 Study design: Interventions. Using aforementioned literature, the study 
was designed to consist of five physiological interventions to alter BP including cold 
pressor, mental arithmetic, breath holding, slow breathing, and hand raising and 
lowering. Due to logistical issues with data collection, the hand raising and lowering 
intervention was removed from analysis. The cold pressor, mental arithmetic, and 
breath holding procedures were intended to increase the BP of the participants 
temporarily, as noted in prior literature. On the other hand, the slow breathing 
intervention was implemented to temporarily reduce BP levels in the participant. 
Between each intervention, there was a 90 second rest period that allowed the 
physiological responses of the participant to return to baseline (see Figure 9 for a 
depiction of all interventions). This also prevented effects from one intervention from 
carrying over into the subsequent intervention.   
Prior to the start of interventions, a baseline BP level was obtained by allowing 
the participant to stand still on the BCG scale for 60 seconds. This was considered Rest 
Period 1 (R1) (see Figure 9 for schematic on study procedures) . Following this rest 
period, the first intervention, cold pressor (CP), began which lasted for 180 seconds. 
This intervention required the left arm of the participant to be submerged in ice water 
for the duration of the intervention. If this intervention caused excessive discomfort for 
the participant, they were permitted to remove their hand from the bucket of ice water 
and proceed with the rest of the study. Previous literature has shown that immersing an 
extremity in ice water can lead to a sudden and noticeable spike in BP levels (Hines & 





 After this intervention, the participant had a second rest period (R2) that lasted 
90 seconds. Then, the next intervention, mental arithmetic (MA), began for a total of 
120 seconds. This intervention required the researcher to provide the participant with a 
mathematical problem that they had to mentally solve as quickly as possible. Subjects 
were given a three-digit number (e.g., 123) and asked to sum the individual digits in 
the number (e.g., 1+2+3=6). Then, the subject was instructed to add this value to the 
original number (e.g., 123+6=129) and to provide the final answer back to the 
researcher. Incorrect responses resulted in the researcher repeating the same problem 
and asking the participant to redo the mathematical problem in an effort to add stress 
and tension to the situation. 
 Upon completion of the mental arithmetic task, a third rest period (R3)  lasting 
90 seconds was done to allow BP levels to return to baseline. The next intervention 
required participants to slow breathe (SB). As mentioned in previous studies, slow 
breathing has been shown to low BP levels due to the dilation of arteries (Grossman, 
2001;  Elliott et al., 2007). Subjects were instructed to breathe in for a few seconds and 
then breathe out for the same length of time. After the slow breathing exercise, another 
rest period (Rest Period 4 (R4)) allowed the BP levels to return to normal before the 
next intervention. This subsequent intervention required the the subject to hold their 
breath for as long as possible, to a healthy and comfortable extent. Responses to the 
breath holding exercise lasted anywhere from a few seconds to over a minute. This 
intervention was intended to once again, increase the BP level.  
 Finally, after a fifth rest period (R5), the participants completed a hand raising 





to maneuver their hand in 5 different positions (HAL) (first position was 10 cm above 
subject’s height and the next four positions went down in 20 centimeter increments). 
However, due to technological errors resulting from this intervention and difficulty 
analyzing this data, this intervention was not included in the final analysis. The study 
concluded with a sixth, and final, rest period.  
 
 
Figure 9. Procedure for human subject study. Each intervention was coupled with a 
90 second rest period to return vitals to baseline levels. CP= Cold pressor, MA= 
Mental arithmetic, SB= Slow breathing, BH= Breath holding, HAL= Hand raising 
and lowering 
 
3.1.4 Survey. A ten question survey was administered to the participants upon 
completion of the study. This was known as the “Post Test Survey” (see Appendix X 
for full survey). The survey included the following questions: How comfortable was 
the [Nexfin, ECG sensor, brachial accelerator, wristband, and PPG sensor]?, What 
location was it most comfortable to wear a sensor for long periods of time?, Have you 
owned a fitness tracker before?, Do you own an ambulatory blood pressure monitor at 
home?, and How much would you pay for a device that could continuously measure 
Blood Pressure? Participants rated their responses for the first question on a Likert 
scale ranging from 1 (least comfortable) to 5 (most comfortable). The purpose of this 
study was to gauge public opinion on measuring blood pressure as a basis for future 
research to explore those options. It also helped reveal what qualities and locations are 





3.2 Data Analysis Methodology 
It was necessary that the team understood and processed the information 
gathered by the human subject study in order to analyze trends, draw correlations 
between key signal features, and produce meaningful conclusions to support this thesis. 
With the help of Yang Yao (a visiting student of the team’s principal investigator, Dr. 
Jin-Oh Hahn), the team was able to use filtering techniques and a graphical user 
interface (GUI) to process the data collected by multiple sensors. This data, as 
described by the human subject methodology, was collected by sensors placed in 
multiple location on the subjects’ bodies. A MATLAB script was written to filter out 
signal noise using several methods. These methods included frequency domain analysis 
of the collected signals for filtering out DC components of measured data (such as 
instrument bias) as well as high frequency components not important to the slow 
moving signals of PPG or BCG.  This meant bandpassing the signal based on 
characteristics of the signals in the frequency domain. Figure 10 shows the process by 
which these signals were collected, filtered, and what was additionally required to 
ensure usability.  
 







3.2.1 Feature Identification. Error in the collection process was evident after 
processing the subjects data. Each sensor had its own inherent error and the collection 
process itself included some human error that varied from subject to subject. Some 
possible sources of error were incorrect documentation of intervention start and end 
time, sensor noise associated with placement on the human body, changes in signal 
power over time, and interruption in the data collection process. Sensor noise was often 
associated with accelerometer noise due to subject moving during the study, PPG noise 
due to sliding of sensor over the finger, or other random noise. Error in peak detection 
due to changes in signal power had to be corrected manually by changing thresholds 
for feature detection. Interruption in the collection process was encountered when some 
subjects became fatigued or lightheaded during interventions, requiring the team to 
pause briefly or end the session entirely.  
It was important that the team identify which subjects’ data was usable for 
further analysis. Of the 35 subjects monitored, 20 were usable and consistent while the 
remaining 15 were not for the reasons described above. In some cases, sensors were 
improperly placed or timing references were not properly recorded. Each signal 
received from the sensors had associated characteristic features that can be identified. 
Some subjects were found to have resting systolic blood pressure of over 160, who 
were excluded due to having blood pressure much higher than what was expected for 
the study. Using this method, the team was able to differentiate what signals were 
consistent and where any error may have occurred.   
The first metric that the team used to determine the usability of a subject’s data 





domains were filtered based on the second and third peaks in the scale BCG spectrum 
for all interventions. In some cases the signal noise was too erratic and inconsistent, 
making the identification of the second and third peaks impossible. This meant that the 
domain for that subject’s intervention could not be determined since the start, midpoint, 




Figure 11. Frequency domains of a subject for each intervention (In order, rest 1, cold 







Figure 12. Structure of the GUI used to identify errors in the initial filtering and the 
data collection process 
 
 
The GUI was used to identify characteristic peaks of BP/BCG/ECG waveforms 
and allowed for the deletion of misidentified peaks by the data processing script. Figure 
12 shows the characteristic waveform of the BCG signal as well as an erroneous signal 
that required human evaluation. Once the two main signals (BCG/ECG) were filtered 
and evaluated, the remaining signal features were updated. It was required that this 
human evaluation using the GUI was performed for each usable subject and every 
corresponding intervention. After all signals were evaluated, the team developed a 
script for the post-processing of this data. It is this step that allowed for the correlation 
of Pulse Arrival Time (PAT1 & PAT2) and Pulse Transit Time (PTT1 - PTT4) with 






3.2.2 PTT Computation and Correlation Analysis. Upon feature extraction, 
the different metrics PAT1, PAT2, and the PTT1-PTT4 needed to be calculated.  A 
separate program was given the data from the preprocessing.  The preprocessing 
provided values of systolic blood pressure (SBP), diastolic blood pressure (DBP) as 
well as the times that these pressures occurred.  It also provided time locations of the 
R-wave in the ECG waveform, peaks and troughs in the PPG waveform, as well as I-
wave and J-wave in the arm BCG waveform.  The post processing program is meant to 
take these time references and measure PAT and PTT for specific beats. 
The program sets out to find the correlation between each separate PAT/PTT 
and BP.  To do this, we utilize each intervention as a data point, where an average value 
of PAT/PTT within that intervention would be plotted against the average SBP/DBP 
during that intervention.  Assuming each of the interventions worked properly, there 
would be a good range of blood pressures and PTT/PAT present to show a clear 
relationship between these two variables.  Below in Figure 13 is an example output of 






Figure 13. Correlation Output 
 
There was found to be much variation in heart rate over the course of each 
intervention.  Since this can introduces variability in PTT and PAT measurements, we 
selected only seven adjacent beats to remove some of the variability associated with 
changing heart rate over time.  Seven was chosen to be small enough that there would 
not be much variation in heart rate or BP over this interval, but large enough to contain 
a larger sampling of points.  To select the seven beats, the program first found the global 
minimum or maximum value of SBP depending on whether the intervention was meant 
to increase or decrease SBP with rest periods taken as minimums.  Then the program 





and correlated with BP.  Thus an array of 7 beats with their corresponding values of 
PAT/PTT could be stored with corresponding values of SBP/DBP at those points 
centered around a maximum/minimum point considered characteristic of the 
intervention. 
With a starting beat, the program is now able to begin finding PAT/PTT.  To 
achieve this, the program first retrieves the nearest time location of an R-wave before 
the time of the SBP maximum occurring.  Then the program stores the next R-wave 
occurring after the max in SBP.  To evaluate if these two R-waves are appropriately 
spaced, the program evaluates the difference in time between them (the beat period) 
and decides to skip the beat if the heart rate is above 180bpm or below 30bpm 
(considered unacceptable limits).  If the program chooses to skip a beat, it will move to 
the next SBP value available and continue storing beats until 7 acceptable beats are 
found.  So skipping a beat does not make the sample size within an intervention smaller, 
it just makes the time window over the sample larger to include 7 usable beats.  Seven 
was chosen because it was a short enough period of time to have a relatively constant 
heart rate, but large enough to sample a characteristic number of points. 
After finding acceptable ECG R-waves, the program next evaluates the PPG 
waveform.  It checks for the first PPG max occurring after the initial R-wave.  It then 
checks that this PPG max occurred before the second R-wave.  If it did not, it skips this 
beat.  This skip means that there is no PPG max available for this beat and therefore it 
must be skipped.  After finding an appropriate PPG max, the program finds the first 
PPG foot available before the stored PPG max.  The program then finds the amount of 





period, it means that the PPG foot does not correspond to this max, and therefore this 
beat does not have a foot available.  Thus this beat must be skipped for another with a 
foot that is available. 
Upon finding appropriate PPG references, the program next finds the first J-
wave in the BCG waveform to occur within the period defined by the 2 ECG R-
waves.  If a J-wave does not exist in this interval, the beat is skipped.  If the J-wave 
does exist, the I-wave before this J-wave is found.  The time lapsed between I-wave 
and J-wave is then evaluated.  If this time is greater than the heart period, the beat is 
skipped, meaning that the available I-wave did not correspond to the current beat. 
With all timing references available, the values of SBP and DBP for each beat 
is stored in an array.  Then the values of PAT/PTT are calculated using the timing 
references.  The metrics are defined as follows: 
 
PAT1: ECG R wave - PPG foot 
PAT2: ECG R wave - PPG maximum 
PTT1 and PTT2: BCG I wave - PPG foot and maximum 












Figures 14 and 15 show where on the waveform these timing references are located. 
 
Figure 14. Shows where on the waveform PAT1 and PAT2 are located. 
 





Upon obtaining 7 values of PAT1/2 and PTT1/2/3/4 the median of these 
PAT/PTT is calculated.  The median was chosen since often large outliers due to 
mismeasurement of characteristic points created large outliers within the 7 data 
points.  Next a median value for SBP and DBP was obtained across each intervention.  
Finally, a plot was obtained of the PAT/PTT against SBP/DBP was obtained and a 
linear regression model was used to calculate a value of correlation coefficient.  These 
correlations were then stored in an array with one coefficient for each metric (PAT1/2 
and PTT1/2/3/4) for each subject. 
3.3: Evolution of Project 
When the team was formed in 2016 the first goal was to make a stand-alone 
device that users could wear. This device was supposed to be able to measure an 
individual’s blood pressure continuously without the need of a blood pressure cuff. 
Originally, the team wanted to incorporate what was coined “The Thermal Method”, 
into the device in order to calculate blood pressure. The thermal method mechanism 
was to measure the movement of blood by tracking a previously heated segment of the 
blood through different parts of the body. This in turn would output values such as 
distance and time, which then would allow the device to calculate blood pressure. 
Unfortunately, this method of measuring blood pressure wasn’t possible, but the team 
wanted to stick with the original goal of a stand alone device. This led the team to the 
second method attempted, “The Magnetic Method.” The magnetic method was similar 
to the thermal method, in which the users blood velocity was measured using changes 
in magnetic fields of moving magnetized blood. Essentially, part of the user’s blood 





then output the proper variables needed to calculate blood pressure. This is using the 
theory known as the Hall Effect, where a potential difference is created across a 
magnetic field. This method also was scrapped as the feasibility of it was drawn into 
question.  
After these minor setbacks, the team decided it was best if we didn’t attempt to 
make and market a stand-alone device, which was proving to be difficult in such a short 
time frame. However, maybe it would be possible to create a phone application that 
could do just this. The application would use SCG signals from the chest and PPG 
signals from the finger using the phones accelerometer and phone camera respectively. 
These signals, the SCG and PPG, would allow the app to calculate the users PTT in 
real time. Then the PTT values with the PPG values would output blood pressure. 
Unfortunately, this phone application also had unforeseen obstacles such as a lack of 
expertise in programming and time constraints, so the team thought it would be best to 
take another route. This then led the team to their final goal which was, data processing 
using human subjects. In other words, the goal was to develop a mechanism for 
analyzing the signals obtained from a human subject study to draw meaningful 
conclusions from the data. The team was split up into two specialized groups. One 
group spent its time in the lab obtaining vitals from different participants while they 
partook in the intervention activities. These vitals were then saved and sent to our other 
team who developed an algorithm that could take these signals and turn them into a 
blood pressure reading. These signals included blood oxygen content, PTT, ECG 
waves, SCG, PPG and accelerometer readings. The goal was to maximize one’s ability 






In order to execute this project, adequate funding and budgeting were required. 
Finances were handled through a financial liaison who was granted $600 dollars per 
academic semester by the Gemstone office. These funds were guaranteed for about 4 
months in the fall and spring. Unused funds from one semester were unable to be rolled 
over to the next semester. This was considered heavily in purchasing decisions in order 
to best utilize funds. In order to determine if additional funding would be necessary to 
execute different aspects of the project, the financial liaison mapped out a three year 
budget at the end of the first year to gauge whether or not the team would have to apply 
for external funds through grants. This budget plan would be adjusted as the project 
evolved. Ultimately, a decision was made in the spring of 2017 that external sources of 
funding would not be needed in order to meet our goals for our project.  
 Purchases corresponding with the team budget began in the fall of 2016. These 
purchases were approved by the financial liaison and by the Assistant Director of 
Operations. Once funds were granted to the team, the budget was allocated towards the 
procurement of bread boards, magnets, and hall sensors in 2016. At this stage, the team 
was intent on creating a non-invasive wearable device that continuously measured 
blood pressure. These tools were necessary to explore different methods to measure 
blood pressure. After the fall of 2016, the budget for the subsequent three semesters 
was allocated solely towards human subject testing. During this time $750 dollars were 
used towards compensating subjects at a rate of 20 dollars per test. One hundred dollars 
from this allocation was used to buy coolers to preserve frozen ice for the cold pressor 





cleaning supplies and antibacterial wipes to create a sterile testing space and give 
subjects a safe and pleasant experience. In addition to the funds used through the 
Gemstone budget, the team’s mentor, Dr. Hahn, granted external funds in order to 
conduct additional subject testing and collect a more complete and diverse sample size.  
Chapter 4: Results 
4.1: Human Subject Study Results 
The obtained average value of the correlation coefficient across the 20 subjects 
that were analyzed was found to be very different between metrics. Table 3 below 
provides values of correlation coefficient -r for each metric against SBP as well as 
performance among quartiles of subjects.  The value of -r is given to avoid placing 
minus signs in front of every cell.  Q1 is the first quartile, Q2 is the median, Q3 is the 
third quartile, and the last row is the standard deviation of the Pearson correlation 
coefficient r. The Best category in Table 3 contains data that was gathered by selecting 
the highest r-value from the measurement methods (i.e. PAT1, PAT2, etc.) for each 
subject.  
Table 3:  Performance of metric in predicting Systolic Blood Pressure 
Systolic PAT1 PAT2 PTT1 PTT2 PTT3 PTT4 Best 
AVG 0.688081 0.729635 0.422985 0.430566 0.496144 0.524975 0.796804 
Q1 0.479717 0.51814 0.168889 0.175854 0.207193 0.235765 0.752062 
Q2 (MED) 0.716333 0.801752 0.350944 0.353652 0.338271 0.448593 0.841337 
Q3 0.860213 0.878484 0.498768 0.541538 0.6078 0.669912 0.90036 






Table 4 below shows the performance of each metric for DBP using -r once again.  The 
r is negative since smaller PAT/PTT corresponds to higher blood velocity and therefore 
higher BP. 
Table 4:  Performance of metric in predicting Diastolic Blood Pressure 
 
Diastolic PAT1 PAT2 PTT1 PTT2 PTT3 PTT4 Best 
AVG 0.658266 0.712125 0.448473 0.449139 0.494461 0.537834 0.781261 
Q1 0.308558 0.466688 0.09023 0.087721 0.230233 0.321438 0.683589 
Q2 (MED) 0.713728 0.807018 0.26726 0.281335 0.307302 0.490295 0.828498 
Q3 0.85281 0.839798 0.643141 0.667316 0.66148 0.666719 0.885838 
Stand Dev 0.291675 0.267534 0.255478 0.255261 0.267261 0.236763 0.20739 
 
 
The root mean square error was calculated to determine how far off of the 
predicted line the measurements were found to be on average.  The values of root mean 
square error (RMSE) are found in the table below for all of the interventions for systolic 
blood pressure. 
Table 5: RMSE in systolic blood pressure in mmHg 
Systolic PAT1 PAT2 PTT1 PTT2 PTT3 PTT4 
AVG 12.11249 11.40379 16.51401 16.44986 14.97978 14.77606 
Q1 9.15388 7.988515 11.95547 11.88434 10.41303 10.40102 
Q2 11.72283 10.20322 15.18092 14.36025 14.47762 14.11507 
Q3 13.55096 13.76893 20.62977 20.66333 18.24279 18.07131 
Std Dev 4.874713 4.873283 5.917459 5.915116 5.266967 5.065745 
 







Table 6: RMSE in diastolic blood pressure in mmHg 
 
Diastolic PAT1 PAT2 PTT1 PTT2 PTT3 PTT4 
Avg 7.70574 7.060575 10.05336 10.05351 9.431654 9.09604 
Q1 6.01231 5.578805 6.731597 6.536714 6.645191 5.926041 
Q2 7.361244 6.268726 9.077824 8.998052 9.354402 9.564114 
Q3 8.059138 7.309004 12.61686 12.65087 11.75841 11.54723 
Std Dev 2.858637 2.957188 4.325729 4.308349 3.812078 3.627143 
 
4.2: Survey Results 
Based on the survey given at the conclusion of the human subjects testing that 
can be found in the appendix, Figures 15 through 20 below show the answers recorded. 
The two most comfortable locations were found to be the upper arm and the chest.  
 
Figure 16. Answers to Question 1: How comfortable was the Nexfin, ECG sensor, 
Brachial acceleration sensor, wrist band, PPG sensor? Participants could answer 












Figure 17. Answers to survey question 2: What location was it most comfortable to 
wear a sensor for long periods of time?  Participants could answer with an integer 1 - 
10 with 1 being the least comfortable and 10 being the most comfortable. Axis shows 
number of participants endorsing each statement. 
 
Figure 18. Answers to survey question 3: Have you owned a fitness tracker (such as a 




















Figure 19. Answers to survey question 4: Do you own an ambulatory blood pressure 




Figure 20. Answers to survey question 5 (bar graph): How much would you pay for a 
device that could continuously measure blood pressure?  The x-axis shows the 









Chapter 5:  Discussion 
5.1 Correlation between BP and PTT 
The results of human subject study generally show that the waveforms that were 
most prominent performed better in predicting both SBP and DBP.  Our study found 
the metric PAT2 to be most highly correlated and best fit for predicting both SBP and 
DBP over all other metrics tested.  The correlation we obtained of approximately 0.73 
is comparable to similar studies measuring PAT2 (Kim et al., 2015).  The RMSE for 
PAT2 was also found to be the best at 11.4 mmHg.  Correlations for DBP in this study 
were higher than those obtained in this previous study.  The correlation found for PTT 
was lower than what was obtained in this previous study, with our study obtaining -r = 
0.52 for PTT4 and less for the remainder of the PTT metrics.  Our PTT were obtained 
using the BCG waveform collected from the subject’s arm.  This arm BCG waveform 
was chosen based on the level of comfort given by the subjects for the arm band.  
Measuring BCG waveforms from the arm introduces additional noise due to small 
movements made by the subject. 
 These small movements introduce noise into the BCG signal at a power that is 
much greater than the signal power of the BCG.  This very low level of SNR leads to 
shifts in key features in the BCG waveform, such as the I and J waves.  This can account 
for some of the reduction in performance we observe in the PTT measurement as 
compared to the previous studies which obtained higher values of the correlation using 






Overall, we found that the PAT1/2 performed better than any of the PTT 
metrics.  This contradicts the previous study which found PTT to be more highly 
correlated with SBP.  However this previous study did not use an arm accelerometer to 
obtain BCG and were therefore able to obtain a higher signal to noise ratio (SNR) in 
their BCG measurement with reduction in noise due to erratic movements of the subject 
during testing.  Since a BCG scale is not something that can be stood on at all times, 
we conclude that moving towards a continuous mobile measurement of BP, it would 
be better suited using PAT2 since it uses PPG and ECG sensors which have less noise 
associated with motion and could be worn comfortably while the subject is active 
throughout the day.  Thus, in the case of mobile application it is better to opt for signals 
which are less noisy and whose timing references are less likely to shift due to noise 
generated by motion. 
PTT 3 and 4 are found to outperform the PTT 1 and 2 which again contradicts 
previous studies. (Kim et al., 2015) The PTT 1 and 2 correspond to measurements using 
the I-wave as the proximal timing reference.  The I-wave is considered a better metric 
since it corresponds to the actual ejection of blood from the heart and therefore directly 
measures the PTT.  The J-wave is reverberation caused by this ejection and can vary 
slightly over different beats.  Since it does not directly correspond to the actual PTT, it 
is considered a weaker measure of PTT and the I-wave is generally used.  However, 
this study has found that the J-wave outperforms the I-wave in this case.  This is due to 
limitations in signal processing which prevent the I-wave from always being measured 
accurately.  Since the J-wave is larger peak and therefore a higher energy signal, it is 





it provides a higher SNR and more prominent peak.  Thus the J-wave is found to be 
better suited for a mobile application which involves high noise since it is more robust 
to additional noise. 
Generally, the metrics involving the foot of the PPG waveform (PAT1, PTT1 
and PTT3) performed worse than their counterparts using the maximum of the PPG as 
the distal timing reference.  While the difference is often small, it is found across every 
pair of signals measured in both the SBP and DBP cases.  This may be due to similar 
issues with additional noise causing larger shifts in the measurement of the foot 
features.  So with the maximum easier to obtain and more robust to noise, it may also 
provide the best distal timing reference for measurement of both PAT and PTT in the 
case of mobile measurement where the PPG sensor might be slightly slipping over the 
subject introducing noise into the measurement. 
Several subjects were found to have higher correlations in both SBP and DBP 
using PTT over the PAT case.  This could be due to several extrinsic factors, such as 
how much the subject moved during testing or the signal power of each signal 
dependent on the measurement in each subject.  If the best metric is used for each 
subject, it is found that these PAT/PTT methods are able to provide a correlation of 
approximately -r = 0.80 which is comparable to previous studies. (Kim et al., 2015). 
 
5.2 Insights on Potential Implementation 
One of the results from the human subjects testing survey tells us what part of 
the body participants found most comfortable to continuously wear a BP measuring 





accelerometer), with 35.7% of the people preferring this location.  The second most 
comfortable position was on the chest (the ECG electrodes), with 32.1%.  The last three 
locations were the wrist, the finger, and the wrist and finger, with 17.8%, 7%, and 7% 
respectively. 
 Interestingly, the data highlights the placement of the ECG electrodes as the 
second most comfortable location. Although this location may sound unusual, many 
participants commented that the sensors were practically unnoticeable on the upper 
chest. Past research of a continuous BP measurement device generally focuses on the 
wrist or fingers but findings such as these could to lead to further research into a blood 
pressure devices for the chest instead. 
 In order to get a blood pressure measurement, we need to get a combination of 
PPG, BCG, and ECG readings.  Most smartphones today come with built in 
accelerometers that can measure BCG data as well as have the ability to record PPG 
measurements as well.  Being able to measure the ECG would allow blood pressure to 
be able to be calculated by the use of the smartphone and an auxiliary device, using the 
same means we calculated it as described above.  This device could be the ECG chest 
sensors.  Additionally, from our data analysis, we found ECG was easiest to process 
and was rated one of the most preferred sensor locations by participants, which shows 
that this would be a feasible placement for sensors. 
5.3 Market Analysis 
Among our subjects, all of whom were college students, 50% of surveyed 
subjects said they would not spend any money or would expend minimal finances on 





device of this nature. According to the 2016 Centers for Disease Control, it is estimated 
that 67 million American adults suffer from high blood pressure, yet only half of them 
have their blood pressure under control (O’Brien, 2018). Additionally, hypertension is 
the cause of approximately 1000 deaths per day in America, costing the U.S. healthcare 
system $47.5 billion yearly medical expenses (O’Brien, 2018). The Global Blood 
Pressure Cuffs Market is project to have a compounded annual growth rate of 7.1% 
from 2015 to 2020 (O’Brien, 2018). In a market that already yields 47.5 billion dollars 
this annual growth rate is significant. The rising growth rate that we have experienced 
during the lifespan of this project paired with the money that has already been spent 
managing hypertension, which shows that there is value in research that could make 
continuous blood pressure measurement more accessible. While college students did 
not seem interested in spending any of their limited income on one of these devices, 
their opinions can change easily in the upcoming years. Furthermore, we believe our 
survey was skewed by the age range of our participants, and would expect different 
results if older people were utilized as subjects throughout our research. 
Additionally, the market is not just shaped by those who have hypertension and 
need to monitor their blood pressure at all times. In fact, around 80% of American 
adults and adolescents are insufficiently active on a daily basis (Piercy, 2018).  Our 
research that aims to create efficient methods for continuous blood pressure 
measurement could be best marketed as a feature for an exercise and wellness app that 
helps people achieve wellness at all levels. For example, this device could let anyone 
from a child ages 6-17 know that they should do 60 minutes or more a day of moderate 





activity a week (Piercy, 2018). A device that could include so many unique aspects of 
health while also continuously observing blood pressure would be extremely enticing 
to the increasingly healthy lifestyle the new generations are enamored with. Along with 
this, people can see if there is a problem with their blood pressure through these 
devices. Instead of not being able to realize there could be a problem until a annual 
checkup with a doctor, someone could notice issues with their blood pressure at any 
time of the year and get it examined before further problems occur.   
 
Chapter 6:  Conclusion 
 
Overall, this study was successful in collecting and analyzing data on 20 human 
subjects.  Findings from the human subjects survey informed the further analysis of 
sensor data to focus only on sensors which subjects found more comfortable.  Using 
sensors to collect ECG, PPG, and BCG waveforms, several measurements of PAT and 
PTT were obtained.  Correlating these measured PAT/PTT values to SBP and DBP 
resulted in comparable results to previous studies.  From results, it was concluded that 
most robust measurements were best suited for a mobile measurement system since 
increased noise due to mobile sensors requires an increased SNR for detecting signal 
characteristics for timing references.  Thus, it was found that R-wave of ECG and 
maximum of the PPG wave provided the highest correlation due to their ease of 
detection and robustness against signal noise. 
 Future areas of research could be conducted in developing a neural net for 
determining which beats are worth processing.  Looking at Figure 20 below, it depicts 






Figure 21.  Example of raw data for a subject with low correlation 
 
In this case, it may be useful to employ a neural network to perform clustering 
for separation of the group of points on the right which exist outside of the general 
trend.  This would be useful for many subjects whose data sets had high correlation for 
large group of points.  In this case, a group of points whose PTT is outside of reasonable 
range is measured.  A neural network could classify points as appearing in one region 
or another which would allow for points occurring in the unreasonable region for a 
particular subject to be disregarded. 
Other limitations of this study include the use of a laboratory setting and 





lower when implemented in a noisy environment likely to be encountered by an actual 
mobile application.  Other limitations may include limited memory and computing 
power.  While we believe that these obstacles could be overcome, further research 
needs to be done to demonstrate that a mobile application is feasible in a real-time 
environment. 
In conclusion, we successfully were able to demonstrate prediction of blood 
pressure using pulse transit time metrics.  Our obtained correlations were similar to 
those found in previous studies.  These results can be used to inform the design and 
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